{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:05:16Z","timestamp":1789016716900,"version":"build-2803163510"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","award":["KP2018\u20100005"],"award-info":[{"award-number":["KP2018\u20100005"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","award":["PR2017\u20100113"],"award-info":[{"award-number":["PR2017\u20100113"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","award":["TJ2017\u20100021"],"award-info":[{"award-number":["TJ2017\u20100021"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","award":["PROF06\/001"],"award-info":[{"award-number":["PROF06\/001"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","award":["PR2015\/005"],"award-info":[{"award-number":["PR2015\/005"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","award":["PR2013\u20100002"],"award-info":[{"award-number":["PR2013\u20100002"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","award":["PR2014\u20100048"],"award-info":[{"award-number":["PR2014\u20100048"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","award":["TJ2016\u20100040"],"award-info":[{"award-number":["TJ2016\u20100040"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","award":["PR2016\u20100044"],"award-info":[{"award-number":["PR2016\u20100044"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","award":["PR2018\u20100016"],"award-info":[{"award-number":["PR2018\u20100016"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","award":["FR2017\u20100154"],"award-info":[{"award-number":["FR2017\u20100154"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["19\u20100056\u2010JIA"],"award-info":[{"award-number":["19\u20100056\u2010JIA"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CAN 2014\/814"],"award-info":[{"award-number":["CAN 2014\/814"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CAN 2012\/770"],"award-info":[{"award-number":["CAN 2012\/770"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CAN 2015\/255"],"award-info":[{"award-number":["CAN 2015\/255"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CAN 2013\/396"],"award-info":[{"award-number":["CAN 2013\/396"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CAN 2016\/275"],"award-info":[{"award-number":["CAN 2016\/275"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CAN 2017\/517"],"award-info":[{"award-number":["CAN 2017\/517"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CAN 2017\/774"],"award-info":[{"award-number":["CAN 2017\/774"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Svenska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","award":["SLS\u2010875361"],"award-info":[{"award-number":["SLS\u2010875361"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006350","name":"Stiftelsen Clas Groschinskys Minnesfond","doi-asserted-by":"publisher","award":["M18228"],"award-info":[{"award-number":["M18228"]}],"id":[{"id":"10.13039\/501100006350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009759","name":"Harald och Greta Jeanssons Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009759","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007435","name":"\u00c5ke Wiberg Stiftelse","doi-asserted-by":"publisher","award":["M18\u20100012"],"award-info":[{"award-number":["M18\u20100012"]}],"id":[{"id":"10.13039\/100007435","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004722","name":"Stiftelsen Lars Hiertas Minne","doi-asserted-by":"publisher","award":["FO2018\u20100002"],"award-info":[{"award-number":["FO2018\u20100002"]}],"id":[{"id":"10.13039\/501100004722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007508","name":"Stiftelsen Sigurd and Elsa Goljes Minne","doi-asserted-by":"publisher","award":["LA2018\u20100038"],"award-info":[{"award-number":["LA2018\u20100038"]}],"id":[{"id":"10.13039\/501100007508","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018\u201002114"],"award-info":[{"award-number":["2018\u201002114"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2015\u201002498"],"award-info":[{"award-number":["2015\u201002498"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2011\u20103897"],"award-info":[{"award-number":["2011\u20103897"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2012\u20105935"],"award-info":[{"award-number":["2012\u20105935"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2013\u20103791"],"award-info":[{"award-number":["2013\u20103791"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2015\u201000162"],"award-info":[{"award-number":["2015\u201000162"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["829\u20102009\u20106241"],"award-info":[{"award-number":["829\u20102009\u20106241"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007232","name":"Radiumhemmets Forskningsfonder","doi-asserted-by":"publisher","award":["154242"],"award-info":[{"award-number":["154242"]}],"id":[{"id":"10.13039\/501100007232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007232","name":"Radiumhemmets Forskningsfonder","doi-asserted-by":"publisher","award":["171162"],"award-info":[{"award-number":["171162"]}],"id":[{"id":"10.13039\/501100007232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007232","name":"Radiumhemmets Forskningsfonder","doi-asserted-by":"publisher","award":["174122"],"award-info":[{"award-number":["174122"]}],"id":[{"id":"10.13039\/501100007232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007232","name":"Radiumhemmets Forskningsfonder","doi-asserted-by":"publisher","award":["191112"],"award-info":[{"award-number":["191112"]}],"id":[{"id":"10.13039\/501100007232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007459","name":"Ragnar S\u00f6derbergs stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["20180318"],"award-info":[{"award-number":["20180318"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["20150353"],"award-info":[{"award-number":["20150353"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["20150016"],"award-info":[{"award-number":["20150016"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["K2892\u20102016"],"award-info":[{"award-number":["K2892\u20102016"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009794","name":"Stiftelsen Felix Mindus Bidrag till Leukemiforskningen","doi-asserted-by":"publisher","award":["2016\u201052575"],"award-info":[{"award-number":["2016\u201052575"]}],"id":[{"id":"10.13039\/501100009794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009794","name":"Stiftelsen Felix Mindus Bidrag till Leukemiforskningen","doi-asserted-by":"publisher","award":["2017\u201001287"],"award-info":[{"award-number":["2017\u201001287"]}],"id":[{"id":"10.13039\/501100009794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009794","name":"Stiftelsen Felix Mindus Bidrag till Leukemiforskningen","doi-asserted-by":"publisher","award":["2018\u201002716"],"award-info":[{"award-number":["2018\u201002716"]}],"id":[{"id":"10.13039\/501100009794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009794","name":"Stiftelsen Felix Mindus Bidrag till Leukemiforskningen","doi-asserted-by":"publisher","award":["2018\u201002715"],"award-info":[{"award-number":["2018\u201002715"]}],"id":[{"id":"10.13039\/501100009794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009794","name":"Stiftelsen Felix Mindus Bidrag till Leukemiforskningen","doi-asserted-by":"publisher","award":["2019\u201002004"],"award-info":[{"award-number":["2019\u201002004"]}],"id":[{"id":"10.13039\/501100009794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010771","name":"Loo och Hans Ostermans Stiftelse f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","award":["2019\u201001128"],"award-info":[{"award-number":["2019\u201001128"]}],"id":[{"id":"10.13039\/100010771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013495","name":"M\u00e4rta och Gunnar V. Philipsons Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013495","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["2016\u201050273"],"award-info":[{"award-number":["2016\u201050273"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["2018\u201001573"],"award-info":[{"award-number":["2018\u201001573"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["2016\u201050756"],"award-info":[{"award-number":["2016\u201050756"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["2018\u201001086"],"award-info":[{"award-number":["2018\u201001086"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["829\u20102009\u20106241"],"award-info":[{"award-number":["829\u20102009\u20106241"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["AI136581"],"award-info":[{"award-number":["AI136581"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["GM104198"],"award-info":[{"award-number":["GM104198"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["MH116695"],"award-info":[{"award-number":["MH116695"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mary B\u00e9ve Foundation for Childhood Cancer Research"},{"DOI":"10.13039\/100007464","name":"Torsten and Ragnar S\u00f6derberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009734","name":"Alex and Eva Wallstr\u00f6m Foundation for Scientific Research And Education","doi-asserted-by":"publisher","award":["2017\u201000475"],"award-info":[{"award-number":["2017\u201000475"]}],"id":[{"id":"10.13039\/501100009734","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009734","name":"Alex and Eva Wallstr\u00f6m Foundation for Scientific Research And Education","doi-asserted-by":"publisher","award":["2018\u201000109"],"award-info":[{"award-number":["2018\u201000109"]}],"id":[{"id":"10.13039\/501100009734","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science for Life Laboratories"},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCHA1950\/1\u20101"],"award-info":[{"award-number":["SCHA1950\/1\u20101"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2020,3,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The deoxycytidine analogue cytarabine (ara\u2010C) remains the backbone treatment of acute myeloid leukaemia (AML) as well as other haematological and lymphoid malignancies, but must be combined with other chemotherapeutics to achieve cure. Yet, the underlying mechanism dictating synergistic efficacy of combination chemotherapy remains largely unknown. The dNTPase SAMHD1, which regulates dNTP homoeostasis antagonistically to ribonucleotide reductase (RNR), limits ara\u2010C efficacy by hydrolysing the active triphosphate metabolite ara\u2010CTP. Here, we report that clinically used inhibitors of RNR, such as gemcitabine and hydroxyurea, overcome the SAMHD1\u2010mediated barrier to ara\u2010C efficacy in primary blasts and mouse models of AML, displaying SAMHD1\u2010dependent synergy with ara\u2010C. We present evidence that this is mediated by dNTP pool imbalances leading to allosteric reduction of SAMHD1 ara\u2010CTPase activity. Thus, SAMHD1 constitutes a novel biomarker for combination therapies of ara\u2010C and RNR inhibitors with immediate consequences for clinical practice to improve treatment of AML.<\/jats:p>","DOI":"10.15252\/emmm.201910419","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T05:03:29Z","timestamp":1579237409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Ribonucleotide reductase inhibitors suppress SAMHD1 ara\u2010CTPase activity enhancing cytarabine efficacy"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4368-3855","authenticated-orcid":false,"given":"Sean G","family":"Rudd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Tsesmetzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Sanjiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia BJ","family":"Paulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Sandhow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Kutzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8297-2238","authenticated-orcid":false,"given":"Ida","family":"Hed Myrberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah S","family":"Bunten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2365-1749","authenticated-orcid":false,"given":"Hanna","family":"Axelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azita","family":"Rasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petri","family":"M\u00e4kel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si'Ana A","family":"Coggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharda","family":"Suman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui M","family":"Branca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Mermelekas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elis\u00e9e","family":"Wiita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Walfridsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond F","family":"Schinazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baek","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8100-9562","authenticated-orcid":false,"given":"Janne","family":"Lehti\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios Z","family":"Rassidakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Pokrovskaja Tamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Warpman\u2010Berglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Heyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Grand\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lundb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0629-2126","authenticated-orcid":false,"given":"Jan\u2010Inge","family":"Henter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9597-4112","authenticated-orcid":false,"given":"Torsten","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7384-092X","authenticated-orcid":false,"given":"Thomas","family":"Helleday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9468-4543","authenticated-orcid":false,"given":"Nikolas","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"key":"BFEMMM201910419_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.leu.2401992","volume":"15","author":"M Ahlmann","year":"2001","unstructured":"Ahlmann M, Lanvers C, Lumkemann K, Rossig C, Freund A, Baumann M, Boos J (2001) Modulation of ara\u2010CTP levels by fludarabine and hydroxyurea in leukemic cells. Leukemia 15: 69\u201373","journal-title":"Leukemia"},{"key":"BFEMMM201910419_CR2","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1073\/pnas.1620220114","volume":"114","author":"MF Ahmad","year":"2017","unstructured":"Ahmad MF, Alam I, Huff SE, Pink J, Flanagan SA, Shewach D, Misko TA, Oleinick NL, Harte WE, Viswanathan R et\u00a0al (2017) Potent competitive inhibition of human ribonucleotide reductase by a nonnucleoside small molecule. Proc Natl Acad Sci USA 114: 8241\u20138246","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201910419_CR3","doi-asserted-by":"crossref","first-page":"e1005194","DOI":"10.1371\/journal.ppat.1005194","volume":"11","author":"LH Arnold","year":"2015","unstructured":"Arnold LH, Groom HC, Kunzelmann S, Schwefel D, Caswell SJ, Ordonez P, Mann MC, Rueschenbaum S, Goldstone DC, Pennell S et\u00a0al (2015a) Phospho\u2010dependent regulation of SAMHD1 oligomerisation couples catalysis and restriction. PLoS Pathog 11: e1005194","journal-title":"PLoS Pathog"},{"key":"BFEMMM201910419_CR4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1128\/AAC.03903-14","volume":"59","author":"LH Arnold","year":"2015","unstructured":"Arnold LH, Kunzelmann S, Webb MR, Taylor IA (2015b) A continuous enzyme\u2010coupled assay for triphosphohydrolase activity of HIV\u20101 restriction factor SAMHD1. Antimicrob Agents Chemother 59: 186\u2013192","journal-title":"Antimicrob Agents Chemother"},{"key":"BFEMMM201910419_CR5","doi-asserted-by":"crossref","first-page":"35768","DOI":"10.1074\/jbc.M112.396911","volume":"287","author":"Y Aye","year":"2012","unstructured":"Aye Y, Long MJ, Stubbe J (2012) Mechanistic studies of semicarbazone triapine targeting human ribonucleotide reductase in\u00a0vitro and in mammalian cells: tyrosyl radical quenching not involving reactive oxygen species. J Biol Chem 287: 35768\u201335778","journal-title":"J Biol Chem"},{"key":"BFEMMM201910419_CR6","doi-asserted-by":"crossref","first-page":"9815","DOI":"10.1073\/pnas.1013274108","volume":"108","author":"Y Aye","year":"2011","unstructured":"Aye Y, Stubbe J (2011) Clofarabine 5\u2019\u2010di and \u2010triphosphates inhibit human ribonucleotide reductase by altering the quaternary structure of its large subunit. Proc Natl Acad Sci USA 108: 9815\u20139820","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201910419_CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-6997(25)00026-2","volume":"41","author":"MC Berenbaum","year":"1989","unstructured":"Berenbaum MC (1989) What is synergy? Pharmacol Rev 41: 93\u2013141","journal-title":"Pharmacol Rev"},{"key":"BFEMMM201910419_CR8","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood.V78.11.2937.2937","volume":"78","author":"K Bhalla","year":"1991","unstructured":"Bhalla K, Swerdlow P, Grant S (1991) Effects of thymidine and hydroxyurea on the metabolism and cytotoxicity of 1\u2010B\u2010D arabinofuranosylcytosine in highly resistant human leukemia cells. Blood 78: 2937\u20132944","journal-title":"Blood"},{"key":"BFEMMM201910419_CR9","doi-asserted-by":"crossref","first-page":"e104125","DOI":"10.1371\/journal.pone.0104125","volume":"9","author":"YL Bunimovich","year":"2014","unstructured":"Bunimovich YL, Nair\u2010Gill E, Riedinger M, McCracken MN, Cheng D, McLaughlin J, Radu CG, Witte ON (2014) Deoxycytidine kinase augments ATM\u2010Mediated DNA repair and contributes to radiation resistance. PLoS ONE 9: e104125","journal-title":"PLoS ONE"},{"key":"BFEMMM201910419_CR10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/10245330410001701512","volume":"9","author":"H Cao","year":"2004","unstructured":"Cao H (2004) Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors. Hematology 9: 223\u2013233","journal-title":"Hematology"},{"key":"BFEMMM201910419_CR11","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2217\/pgs.13.131","volume":"14","author":"X Cao","year":"2013","unstructured":"Cao X, Mitra AK, Pounds S, Crews KR, Gandhi V, Plunkett W, Dolan ME, Hartford C, Raimondi S, Campana D et\u00a0al (2013) RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients. Pharmacogenomics 14: 1449\u20131466","journal-title":"Pharmacogenomics"},{"key":"BFEMMM201910419_CR12","first-page":"8507","volume":"13","author":"NM Cerqueira","year":"2007","unstructured":"Cerqueira NM, Fernandes PA, Ramos MJ (2007) Understanding ribonucleotide reductase inactivation by gemcitabine. Chemistry (Weinheim an der Bergstrasse, Germany) 13: 8507\u20138515","journal-title":"Chemistry (Weinheim an der Bergstrasse, Germany)"},{"key":"BFEMMM201910419_CR13","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1158\/1535-7163.MCT-17-0597","volume":"16","author":"YK Chae","year":"2017","unstructured":"Chae YK, Pan AP, Davis AA, Patel SP, Carneiro BA, Kurzrock R, Giles FJ (2017) Path toward precision oncology: review of targeted therapy studies and tools to aid in defining \u201cactionability\u201d of a molecular lesion and patient management support. Mol Cancer Ther 16: 2645\u20132655","journal-title":"Mol Cancer Ther"},{"key":"BFEMMM201910419_CR14","doi-asserted-by":"crossref","first-page":"39267","DOI":"10.1074\/jbc.M006233200","volume":"275","author":"K Chimploy","year":"2000","unstructured":"Chimploy K, Tassotto ML, Mathews CK (2000) Ribonucleotide reductase, a possible agent in deoxyribonucleotide pool asymmetries induced by hypoxia. J Biol Chem 275: 39267\u201339271","journal-title":"J Biol Chem"},{"key":"BFEMMM201910419_CR15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/1042819021000054670","volume":"44","author":"KU Chow","year":"2003","unstructured":"Chow KU, Boehrer S, Napieralski S, Nowak D, Knau A, Hoelzer D, Mitrou PS, Weidmann E (2003) In AML cell lines Ara\u2010C combined with purine analogues is able to exert synergistic as well as antagonistic effects on proliferation, apoptosis and disruption of mitochondrial membrane potential. Leuk Lymphoma 44: 165\u2013173","journal-title":"Leuk Lymphoma"},{"key":"BFEMMM201910419_CR16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF01715122","volume":"65","author":"LP Colly","year":"1992","unstructured":"Colly LP, Richel DJ, Arentsen\u2010Honders MW, Kester MG, ter Riet PM, Willemze R (1992) Increase in Ara\u2010C sensitivity in Ara\u2010C sensitive and \u2010resistant leukemia by stimulation of the salvage and inhibition of the de novo pathway. Ann Hematol 65: 26\u201332","journal-title":"Ann Hematol"},{"key":"BFEMMM201910419_CR17","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1038\/bcj.2016.50","volume":"6","author":"I De Kouchkovsky","year":"2016","unstructured":"De Kouchkovsky I, Abdul\u2010Hay M (2016) Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J 6: e441","journal-title":"Blood Cancer J"},{"key":"BFEMMM201910419_CR18","doi-asserted-by":"crossref","first-page":"51545","DOI":"10.1074\/jbc.M408573200","volume":"279","author":"TL Diamond","year":"2004","unstructured":"Diamond TL, Roshal M, Jamburuthugoda VK, Reynolds HM, Merriam AR, Lee KY, Balakrishnan M, Bambara RA, Planelles V, Dewhurst S et\u00a0al (2004) Macrophage tropism of HIV\u20101 depends on efficient cellular dNTP utilization by reverse transcriptase. J Biol Chem 279: 51545\u201351553","journal-title":"J Biol Chem"},{"key":"BFEMMM201910419_CR19","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1158\/1078-0432.CCR-06-2581","volume":"13","author":"E Drakos","year":"2007","unstructured":"Drakos E, Thomaides A, Medeiros LJ, Li J, Leventaki V, Konopleva M, Andreeff M, Rassidakis GZ (2007) Inhibition of p53\u2010murine double minute 2 interaction by nutlin\u20103A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma. Clin Cancer Res 13: 3380\u20133387","journal-title":"Clin Cancer Res"},{"key":"BFEMMM201910419_CR20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MPH.0b013e318166247e","volume":"30","author":"R Dubowy","year":"2008","unstructured":"Dubowy R, Graham M, Hakami N, Kletzel M, Mahoney D, Newman E, Ravindranath Y, Camitta B (2008) Sequential oral hydroxyurea and intravenous cytosine arabinoside in refractory childhood acute leukemia: a pediatric oncology group phase 1 study. J Pediatr Hematol Oncol 30: 353\u2013357","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFEMMM201910419_CR21","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136: E359\u2013E386","journal-title":"Int J Cancer"},{"key":"BFEMMM201910419_CR22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJMoa0904544","volume":"361","author":"HF Fernandez","year":"2009","unstructured":"Fernandez HF, Sun Z, Yao X, Litzow MR, Luger SM, Paietta EM, Racevskis J, Dewald GW, Ketterling RP, Bennett JM et\u00a0al (2009) Anthracycline dose intensification in acute myeloid leukemia. N Engl J Med 361: 1249\u20131259","journal-title":"N Engl J Med"},{"key":"BFEMMM201910419_CR23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ajh.2830490109","volume":"49","author":"PS Frenette","year":"1995","unstructured":"Frenette PS, Desforges JF, Schenkein DP, Rabson A, Slapack CA, Miller KB (1995) Granulocyte\u2010macrophage colony stimulating factor (GM\u2010CSF) priming in the treatment of elderly patients with acute myelogenous leukemia. Am J Hematol 49: 48\u201355","journal-title":"Am J Hematol"},{"key":"BFEMMM201910419_CR24","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0959-8049(97)10149-6","volume":"34","author":"A Freund","year":"1998","unstructured":"Freund A, Boos J, Harkin S, Schultze\u2010Mosgau M, Veerman G, Peters GJ, Gescher A (1998) Augmentation of 1\u2010beta\u2010D\u2010arabinofuranosylcytosine (Ara\u2010C) cytotoxicity in leukaemia cells by co\u2010administration with antisignalling drugs. Eur J Cancer 34: 895\u2013901","journal-title":"Eur J Cancer"},{"key":"BFEMMM201910419_CR25","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1021\/ac902737j","volume":"82","author":"E Fromentin","year":"2010","unstructured":"Fromentin E, Gavegnano C, Obikhod A, Schinazi RF (2010) Simultaneous quantification of intracellular natural and antiretroviral nucleosides and nucleotides by liquid chromatography\u2010tandem mass spectrometry. Anal Chem 82: 1982\u20131989","journal-title":"Anal Chem"},{"key":"BFEMMM201910419_CR26","first-page":"1517","volume":"55","author":"V Gandhi","year":"1995","unstructured":"Gandhi V, Mineishi S, Huang P, Chapman AJ, Yang Y, Chen F, Nowak B, Chubb S, Hertel LW, Plunkett W (1995) Cytotoxicity, metabolism, and mechanisms of action of 2\u2032,2\u2032\u2010difluorodeoxyguanosine in Chinese hamster ovary cells. Can Res 55: 1517\u20131524","journal-title":"Can Res"},{"key":"BFEMMM201910419_CR27","first-page":"3675","volume":"50","author":"V Gandhi","year":"1990","unstructured":"Gandhi V, Plunkett W (1990) Modulatory activity of 2\u2032,2\u2032\u2010difluorodeoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosides. Can Res 50: 3675\u20133680","journal-title":"Can Res"},{"key":"BFEMMM201910419_CR28","doi-asserted-by":"crossref","first-page":"8333","DOI":"10.1073\/pnas.92.18.8333","volume":"92","author":"WY Gao","year":"1995","unstructured":"Gao WY, Johns DG, Chokekuchai S, Mitsuya H (1995) Disparate actions of hydroxyurea in potentiation of purine and pyrimidine 2\u2032,3\u2032\u2010dideoxynucleoside activities against replication of human immunodeficiency virus. Proc Natl Acad Sci USA 92: 8333\u20138337","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201910419_CR29","first-page":"6923","volume":"49","author":"J Griffig","year":"1989","unstructured":"Griffig J, Koob R, Blakley RL (1989) Mechanisms of inhibition of DNA synthesis by 2\u2010chlorodeoxyadenosine in human lymphoblastic cells. Can Res 49: 6923\u20136928","journal-title":"Can Res"},{"key":"BFEMMM201910419_CR30","doi-asserted-by":"crossref","first-page":"37250","DOI":"10.1038\/srep37250","volume":"6","author":"JR Guo","year":"2016","unstructured":"Guo JR, Chen QQ, Lam CW, Wang CY, Wong VK, Chang ZF, Zhang W (2016) Profiling ribonucleotide and deoxyribonucleotide pools perturbed by gemcitabine in human non\u2010small cell lung cancer cells. Sci Rep 6: 37250","journal-title":"Sci Rep"},{"key":"BFEMMM201910419_CR31","doi-asserted-by":"crossref","first-page":"E1843","DOI":"10.1073\/pnas.1323416111","volume":"111","author":"EC Hansen","year":"2014","unstructured":"Hansen EC, Seamon KJ, Cravens SL, Stivers JT (2014) GTP activator and dNTP substrates of HIV\u20101 restriction factor SAMHD1 generate a long\u2010lived activated state. Proc Natl Acad Sci USA 111: E1843\u2013E1851","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201910419_CR32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-4615-5381-6_49","volume":"431","author":"V Heinemann","year":"1998","unstructured":"Heinemann V, Schulz L, Issels RD, Wilmanns W (1998) Regulation of deoxycytidine kinase by deoxycytidine and deoxycytidine 5\u2032 triphosphate in whole leukemia and tumor cells. Adv Exp Med Biol 431: 249\u2013253","journal-title":"Adv Exp Med Biol"},{"key":"BFEMMM201910419_CR33","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/15384101.2017.1314407","volume":"16","author":"N Herold","year":"2017","unstructured":"Herold N, Rudd S, Sanjiv K, Kutzner J, Bladh J, Paulin CBJ, Helleday T, Henter J\u2010I, Schaller T (2017a) SAMHD1 protects cancer cells from various nucleoside\u2010based antimetabolites. Cell Cycle 16: 1029\u20131038","journal-title":"Cell Cycle"},{"key":"BFEMMM201910419_CR34","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nm.4265","volume":"23","author":"N Herold","year":"2017","unstructured":"Herold N, Rudd SG, Ljungblad L, Sanjiv K, Myrberg IH, Paulin CB, Heshmati Y, Hagenkort A, Kutzner J, Page BD et\u00a0al (2017b) Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies. Nat Med 23: 256\u2013263","journal-title":"Nat Med"},{"key":"BFEMMM201910419_CR35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.exphem.2017.05.001","volume":"52","author":"N Herold","year":"2017","unstructured":"Herold N, Rudd SG, Sanjiv K, Kutzner J, Myrberg IH, Paulin CBJ, Olsen TK, Helleday T, Henter JI, Schaller T (2017c) With me or against me: tumor suppressor and drug resistance activities of SAMHD1. Exp Hematol 52: 32\u201339","journal-title":"Exp Hematol"},{"key":"BFEMMM201910419_CR36","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0145-2126(97)00068-4","volume":"21","author":"M Higashigawa","year":"1997","unstructured":"Higashigawa M, Hori H, Hirayama M, Kawasaki H, Ido M, Azuma E, Sakurai M (1997) Salvage therapy for relapsed or refractory childhood acute lymphocytic leukemia by alternative administration a lymphoid\u2010 and myeloid\u2010directed chemotherapeutic regimen consisting of dual modulation of ara\u2010C, hydroxyurea, and etoposide. Leuk Res 21: 811\u2013815","journal-title":"Leuk Res"},{"key":"BFEMMM201910419_CR37","doi-asserted-by":"crossref","first-page":"e0169052","DOI":"10.1371\/journal.pone.0169052","volume":"12","author":"JA Hollenbaugh","year":"2017","unstructured":"Hollenbaugh JA, Shelton J, Tao S, Amiralaei S, Liu P, Lu X, Goetze RW, Zhou L, Nettles JH, Schinazi RF et\u00a0al (2017) Substrates and Inhibitors of SAMHD1. PLoS ONE 12: e0169052","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"BFEMMM201910419_CR38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/mpo.2950100710","volume":"10","author":"SB Howell","year":"1982","unstructured":"Howell SB, Streifel JA, Pfeifle CE (1982) Modulation of the cellular pharmacology and clinical toxicity of 1\u2010beta\u2010D\u2010arabinofuranosylcytosine. Med Pediatr Oncol 10(Suppl 1): 81\u201391","journal-title":"Med Pediatr Oncol"},{"key":"BFEMMM201910419_CR39","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature10195","volume":"474","author":"K Hrecka","year":"2011","unstructured":"Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik\u2010Brodacka M, Srivastava S, Florens L, Washburn MP, Skowronski J (2011) Vpx relieves inhibition of HIV\u20101 infection of macrophages mediated by the SAMHD1 protein. Nature 474: 658\u2013661","journal-title":"Nature"},{"key":"BFEMMM201910419_CR40","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1081\/NCN-200027727","volume":"23","author":"I Hubeek","year":"2004","unstructured":"Hubeek I, Peters GJ, Broekhuizen AJ, Kaspers GJ (2004) Modulation of cytarabine induced cytotoxicity using novel deoxynucleoside analogs in the HL60 cell line. Nucleosides, Nucleotides Nucleic Acids 23: 1513\u20131516","journal-title":"Nucleosides, Nucleotides Nucleic Acids"},{"key":"BFEMMM201910419_CR41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood.V90.1.270.270_270_278","volume":"90","author":"H Iwasaki","year":"1997","unstructured":"Iwasaki H, Huang P, Keating MJ, Plunkett W (1997) Differential incorporation of ara\u2010C, gemcitabine, and fludarabine into replicating and repairing DNA in proliferating human leukemia cells. Blood 90: 270\u2013278","journal-title":"Blood"},{"key":"BFEMMM201910419_CR42","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1021\/acs.biochem.6b00627","volume":"55","author":"S Jang","year":"2016","unstructured":"Jang S, Zhou X, Ahn J (2016) Substrate specificity of SAMHD1 triphosphohydrolase activity is controlled by deoxyribonucleoside triphosphates and phosphorylation at Thr592. Biochemistry 55: 5635\u20135646","journal-title":"Biochemistry"},{"key":"BFEMMM201910419_CR43","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/nsmb.2692","volume":"20","author":"X Ji","year":"2013","unstructured":"Ji X, Wu Y, Yan J, Mehrens J, Yang H, DeLucia M, Hao C, Gronenborn AM, Skowronski J, Ahn J et\u00a0al (2013) Mechanism of allosteric activation of SAMHD1 by dGTP. Nat Struct Mol Biol 20: 1304\u20131309","journal-title":"Nat Struct Mol Biol"},{"key":"BFEMMM201910419_CR44","doi-asserted-by":"crossref","first-page":"7941","DOI":"10.1128\/JVI.72.10.7941-7949.1998","volume":"72","author":"JG Julias","year":"1998","unstructured":"Julias JG, Pathak VK (1998) Deoxyribonucleoside triphosphate pool imbalances in\u00a0vivo are associated with an increased retroviral mutation rate. J Virol 72: 7941\u20137949","journal-title":"J Virol"},{"key":"BFEMMM201910419_CR45","doi-asserted-by":"crossref","first-page":"25047","DOI":"10.1074\/jbc.M111.234047","volume":"286","author":"EM Kennedy","year":"2011","unstructured":"Kennedy EM, Daddacha W, Slater R, Gavegnano C, Fromentin E, Schinazi RF, Kim B (2011) Abundant non\u2010canonical dUTP found in primary human macrophages drives its frequent incorporation by HIV\u20101 reverse transcriptase. J Biol Chem 286: 25047\u201325055","journal-title":"J Biol Chem"},{"key":"BFEMMM201910419_CR46","doi-asserted-by":"crossref","first-page":"E10022","DOI":"10.1073\/pnas.1805593115","volume":"115","author":"KM Knecht","year":"2018","unstructured":"Knecht KM, Buzovetsky O, Schneider C, Thomas D, Srikanth V, Kaderali L, Tofoleanu F, Reiss K, Ferreiros N, Geisslinger G et\u00a0al (2018) The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1. Proc Natl Acad Sci USA 115: E10022\u2013E10031","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201910419_CR47","doi-asserted-by":"crossref","first-page":"32617","DOI":"10.1074\/jbc.M114.591958","volume":"289","author":"LM Koharudin","year":"2014","unstructured":"Koharudin LM, Wu Y, DeLucia M, Mehrens J, Gronenborn AM, Ahn J (2014) Structural basis of allosteric activation of sterile alpha motif and histidine\u2010aspartate domain\u2010containing protein 1 (SAMHD1) by nucleoside triphosphates. J Biol Chem 289: 32617\u201332627","journal-title":"J Biol Chem"},{"key":"BFEMMM201910419_CR48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/978-1-4684-5676-9_53","volume":"253b","author":"M Kubota","year":"1989","unstructured":"Kubota M, Takimoto T, Kitoh T, Tanizawa A, Akiyama Y, Kiriyama Y, Mikawa H (1989) Ara\u2010CTP metabolism following hydroxyurea or methotrexate treatment in human leukemia cell lines. Adv Exp Med Biol 253b: 363\u2013367","journal-title":"Adv Exp Med Biol"},{"key":"BFEMMM201910419_CR49","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/0006-2952(88)90438-8","volume":"37","author":"M Kubota","year":"1988","unstructured":"Kubota M, Takimoto T, Tanizawa A, Akiyama Y, Mikawa H (1988) Differential modulation of 1\u2010beta\u2010D\u2010arabinofuranosylcytosine metabolism by hydroxyurea in human leukemic cell lines. Biochem Pharmacol 37: 1745\u20131749","journal-title":"Biochem Pharmacol"},{"key":"BFEMMM201910419_CR50","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature10117","volume":"474","author":"N Laguette","year":"2011","unstructured":"Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable\u2010Bessia C, Segeral E, Yatim A, Emiliani S, Schwartz O, Benkirane M (2011) SAMHD1 is the dendritic\u2010 and myeloid\u2010cell\u2010specific HIV\u20101 restriction factor counteracted by Vpx. Nature 474: 654\u2013657","journal-title":"Nature"},{"key":"BFEMMM201910419_CR51","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41467-017-00221-3","volume":"8","author":"TM Le","year":"2017","unstructured":"Le TM, Poddar S, Capri JR, Abt ER, Kim W, Wei L, Uong NT, Cheng CM, Braas D, Nikanjam M et\u00a0al (2017) ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathways. Nat Commun 8: 241","journal-title":"Nat Commun"},{"key":"BFEMMM201910419_CR52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2012-07-444851","volume":"121","author":"B Lowenberg","year":"2013","unstructured":"Lowenberg B (2013) Sense and nonsense of high\u2010dose cytarabine for acute myeloid leukemia. Blood 121: 26\u201328","journal-title":"Blood"},{"key":"BFEMMM201910419_CR53","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood-2015-07-657403","volume":"127","author":"MR Luskin","year":"2016","unstructured":"Luskin MR, Lee JW, Fernandez HF, Abdel\u2010Wahab O, Bennett JM, Ketterling RP, Lazarus HM, Levine RL, Litzow MR, Paietta EM et\u00a0al (2016) Benefit of high\u2010dose daunorubicin in AML induction extends across cytogenetic and molecular groups. Blood 127: 1551\u20131558","journal-title":"Blood"},{"key":"BFEMMM201910419_CR54","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.3109\/10428194.2016.1142083","volume":"57","author":"AC Mamez","year":"2016","unstructured":"Mamez AC, Raffoux E, Chevret S, Lemiale V, Boissel N, Canet E, Schlemmer B, Dombret H, Azoulay E, Lengline E (2016) Pre\u2010treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemia. Leuk Lymphoma 57: 2281\u20132288","journal-title":"Leuk Lymphoma"},{"key":"BFEMMM201910419_CR55","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1089\/ars.2016.6888","volume":"27","author":"C Mauney","year":"2017","unstructured":"Mauney C, Rogers L, Harris R, Daniel L, Devarie\u2010Baez N, Wu H, Furdui C, Poole LB, Perrino F, Hollis T (2017) The SAMHD1 dNTP triphosphohydrolase is controlled by a redox switch. Antioxid Redox Signal 27: 1317\u20131331","journal-title":"Antioxid Redox Signal"},{"key":"BFEMMM201910419_CR56","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.1021\/acs.biochem.8b01038","volume":"57","author":"CH Mauney","year":"2018","unstructured":"Mauney CH, Perrino FW, Hollis T (2018) Identification of inhibitors of the dNTP triphosphohydrolase SAMHD1 using a novel and direct high\u2010throughput assay. Biochemistry 57: 6624\u20136636","journal-title":"Biochemistry"},{"key":"BFEMMM201910419_CR57","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJM199410063311402","volume":"331","author":"RJ Mayer","year":"1994","unstructured":"Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei E 3rd (1994) Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med 331: 896\u2013903","journal-title":"N Engl J Med"},{"key":"BFEMMM201910419_CR58","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1021\/mp5004866","volume":"11","author":"TP Miettinen","year":"2014","unstructured":"Miettinen TP, Bjorklund M (2014) NQO2 is a reactive oxygen species generating off\u2010target for acetaminophen. Mol Pharm 11: 4395\u20134404","journal-title":"Mol Pharm"},{"key":"BFEMMM201910419_CR59","doi-asserted-by":"crossref","first-page":"11569","DOI":"10.1021\/bi00094a013","volume":"32","author":"S Nyholm","year":"1993","unstructured":"Nyholm S, Thelander L, Graslund A (1993) Reduction and loss of the iron center in the reaction of the small subunit of mouse ribonucleotide reductase with hydroxyurea. Biochemistry 32: 11569\u201311574","journal-title":"Biochemistry"},{"key":"BFEMMM201910419_CR60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10637-008-9115-6","volume":"26","author":"OM Odenike","year":"2008","unstructured":"Odenike OM, Larson RA, Gajria D, Dolan ME, Delaney SM, Karrison TG, Ratain MJ, Stock W (2008) Phase I study of the ribonucleotide reductase inhibitor 3\u2010aminopyridine\u20102\u2010carboxaldehyde\u2010thiosemicarbazone (3\u2010AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia. Invest New Drugs 26: 233\u2013239","journal-title":"Invest New Drugs"},{"key":"BFEMMM201910419_CR61","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0959-8049(94)90276-3","volume":"30a","author":"TJ O'Rourke","year":"1994","unstructured":"O'Rourke TJ, Brown TD, Havlin K, Kuhn JG, Craig JB, Burris HA, Satterlee WG, Tarassoff PG, Von Hoff DD (1994) Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days. Eur J Cancer 30a: 417\u2013418","journal-title":"Eur J Cancer"},{"key":"BFEMMM201910419_CR62","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41467-017-02293-7","volume":"9","author":"BDG Page","year":"2018","unstructured":"Page BDG, Valerie NCK, Wright RHG, Wallner O, Isaksson R, Carter M, Rudd SG, Loseva O, Jemth AS, Almlof I et\u00a0al (2018) Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells. Nat Commun 9: 250","journal-title":"Nat Commun"},{"key":"BFEMMM201910419_CR63","first-page":"2386","volume":"51","author":"WB Parker","year":"1991","unstructured":"Parker WB, Shaddix SC, Chang CH, White EL, Rose LM, Brockman RW, Shortnacy AT, Montgomery JA, Secrist JA 3rd, Bennett LL Jr (1991) Effects of 2\u2010chloro\u20109\u2010(2\u2010deoxy\u20102\u2010fluoro\u2010beta\u2010D\u2010arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5\u2019\u2010triphosphate. Can Res 51: 2386\u20132394","journal-title":"Can Res"},{"key":"BFEMMM201910419_CR64","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/prot.25701","volume":"87","author":"KK Patra","year":"2019","unstructured":"Patra KK, Bhattacharya A, Bhattacharya S (2019) Molecular dynamics investigation of a redox switch in the anti\u2010HIV protein SAMHD1. Proteins 87: 748\u2013759","journal-title":"Proteins"},{"key":"BFEMMM201910419_CR65","first-page":"978","volume":"38","author":"PG Plagemann","year":"1978","unstructured":"Plagemann PG, Marz R, Wohlhueter RM (1978) Transport and metabolism of deoxycytidine and 1\u2010beta\u2010D\u2010arabinofuranosylcytosine into cultured Novikoff rat hepatoma cells, relationship to phosphorylation, and regulation of triphosphate synthesis. Can Res 38: 978\u2013989","journal-title":"Can Res"},{"key":"BFEMMM201910419_CR66","first-page":"20","volume":"12","author":"W Plunkett","year":"1985","unstructured":"Plunkett W, Iacoboni S, Estey E, Danhauser L, Liliemark JO, Keating MJ (1985) Pharmacologically directed ara\u2010C therapy for refractory leukemia. Semin Oncol 12: 20\u201330","journal-title":"Semin Oncol"},{"key":"BFEMMM201910419_CR67","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41408-018-0134-z","volume":"8","author":"GZ Rassidakis","year":"2018","unstructured":"Rassidakis GZ, Herold N, Myrberg IH, Tsesmetzis N, Rudd SG, Henter JI, Schaller T, Ng SB, Chng WJ, Yan B et\u00a0al (2018) Low\u2010level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high\u2010dose cytarabine\u2010based regimens. Blood Cancer J 8: 98","journal-title":"Blood Cancer J"},{"key":"BFEMMM201910419_CR68","first-page":"2688","volume":"43","author":"F Rauscher 3rd","year":"1983","unstructured":"Rauscher F 3rd, Cadman E (1983) Biochemical and cytokinetic modulation of L1210 and HL\u201060 cells by hydroxyurea and effect on 1\u2010beta\u2010D\u2010arabinofuranosylcytosine metabolism and cytotoxicity. Can Res 43: 2688\u20132693","journal-title":"Can Res"},{"key":"BFEMMM201910419_CR69","first-page":"1339","volume":"5","author":"M Rieber","year":"1994","unstructured":"Rieber M, Rieber MS (1994) Cyclin\u2010dependent kinase 2 and cyclin A interaction with E2F are targets for tyrosine induction of B16 melanoma terminal differentiation. Cell Growth Differ 5: 1339\u20131346","journal-title":"Cell Growth Differ"},{"key":"BFEMMM201910419_CR70","doi-asserted-by":"crossref","first-page":"11648","DOI":"10.1158\/0008-5472.CAN-07-3100","volume":"67","author":"V Rodriguez\u2010Bravo","year":"2007","unstructured":"Rodriguez\u2010Bravo V, Guaita\u2010Esteruelas S, Salvador N, Bachs O, Agell N (2007) Different S\/M checkpoint responses of tumor and non tumor cell lines to DNA replication inhibition. Can Res 67: 11648\u201311656","journal-title":"Can Res"},{"key":"BFEMMM201910419_CR71","doi-asserted-by":"crossref","first-page":"e1287554","DOI":"10.1080\/23723556.2017.1287554","volume":"4","author":"SG Rudd","year":"2017","unstructured":"Rudd SG, Schaller T, Herold N (2017) SAMHD1 is a barrier to antimetabolite\u2010based cancer therapies. Mol Cell Oncol 4: e1287554","journal-title":"Mol Cell Oncol"},{"key":"BFEMMM201910419_CR72","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0145-2126(95)00106-9","volume":"20","author":"V Santini","year":"1996","unstructured":"Santini V, D'Ippolito G, Bernabei PA, Zoccolante A, Ermini A, Rossi\u2010Ferrini P (1996) Effects of fludarabine and gemcitabine on human acute myeloid leukemia cell line HL 60: direct comparison of cytotoxicity and cellular Ara\u2010C uptake enhancement. Leuk Res 20: 37\u201345","journal-title":"Leuk Res"},{"key":"BFEMMM201910419_CR73","first-page":"3286","volume":"44","author":"A Sato","year":"1984","unstructured":"Sato A, Montgomery JA, Cory JG (1984) Synergistic inhibition of leukemia L1210 cell growth in\u00a0vitro by combinations of 2\u2010fluoroadenine nucleosides and hydroxyurea or 2,3\u2010dihydro\u20101H\u2010pyrazole[2,3\u2010a]imidazole. Can Res 44: 3286\u20133290","journal-title":"Can Res"},{"key":"BFEMMM201910419_CR74","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF01469126","volume":"54","author":"H Sauer","year":"1976","unstructured":"Sauer H, Pelka R, Wilmanns W (1976) Pharmakokinetics of hydroxy\u2010urea. Therapy of acute myeoblastic leukemias using synchronization and recruitment effects (author\u2019 transl). Klin Wochenschr 54: 203\u2013209","journal-title":"Klin Wochenschr"},{"key":"BFEMMM201910419_CR75","first-page":"84","volume":"19","author":"RL Schilsky","year":"1992","unstructured":"Schilsky RL, Ratain MJ, Vokes EE, Vogelzang NJ, Anderson J, Peterson BA (1992) Laboratory and clinical studies of biochemical modulation by hydroxyurea. Semin Oncol 19: 84\u201389","journal-title":"Semin Oncol"},{"key":"BFEMMM201910419_CR76","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1200\/JCO.1987.5.3.419","volume":"5","author":"RL Schilsky","year":"1987","unstructured":"Schilsky RL, Williams SF, Ultmann JE, Watson S (1987) Sequential hydroxyurea\u2010cytarabine chemotherapy for refractory non\u2010Hodgkin's lymphoma. J Clin Oncol 5: 419\u2013425","journal-title":"J Clin Oncol"},{"key":"BFEMMM201910419_CR77","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nm.4255","volume":"23","author":"C Schneider","year":"2016","unstructured":"Schneider C, Oellerich T, Baldauf HM, Schwarz SM, Thomas D, Flick R, Bohnenberger H, Kaderali L, Stegmann L, Cremer A et\u00a0al (2016) SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. Nat Med 23: 250\u2013255","journal-title":"Nat Med"},{"key":"BFEMMM201910419_CR78","doi-asserted-by":"crossref","first-page":"9822","DOI":"10.1021\/ja5035717","volume":"136","author":"KJ Seamon","year":"2014","unstructured":"Seamon KJ, Hansen EC, Kadina AP, Kashemirov BA, McKenna CE, Bumpus NN, Stivers JT (2014) Small molecule inhibition of SAMHD1 dNTPase by tetramer destabilization. J Am Chem Soc 136: 9822\u20139825","journal-title":"J Am Chem Soc"},{"key":"BFEMMM201910419_CR79","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/1087057115575150","volume":"20","author":"KJ Seamon","year":"2015","unstructured":"Seamon KJ, Stivers JT (2015) A high\u2010throughput enzyme\u2010coupled assay for SAMHD1 dNTPase. J Biomol Screen 20: 801\u2013809","journal-title":"J Biomol Screen"},{"key":"BFEMMM201910419_CR80","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.bcp.2007.01.025","volume":"73","author":"J Sigmond","year":"2007","unstructured":"Sigmond J, Kamphuis JA, Laan AC, Hoebe EK, Bergman AM, Peters GJ (2007) The synergistic interaction of gemcitabine and cytosine arabinoside with the ribonucleotide reductase inhibitor triapine is schedule dependent. Biochem Pharmacol 73: 1548\u20131557","journal-title":"Biochem Pharmacol"},{"key":"BFEMMM201910419_CR81","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ajh.2830410307","volume":"41","author":"CA Slapak","year":"1992","unstructured":"Slapak CA, Desforges JF, Fogaren T, Miller KB (1992) Treatment of acute myeloid leukemia in the elderly with low\u2010dose cytarabine, hydroxyurea, and calcitriol. Am J Hematol 41: 178\u2013183","journal-title":"Am J Hematol"},{"key":"BFEMMM201910419_CR82","first-page":"157","volume":"19","author":"K Smid","year":"2001","unstructured":"Smid K, Van Moorsel CJ, Noordhuis P, Voorn DA, Peters GJ (2001) Interference of gemcitabine triphosphate with the measurements of deoxynucleotides using an optimized DNA polymerase elongation assay. Int J Oncol 19: 157\u2013162","journal-title":"Int J Oncol"},{"key":"BFEMMM201910419_CR83","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/0006-2952(84)90421-0","volume":"33","author":"RD Snyder","year":"1984","unstructured":"Snyder RD (1984) Deoxyribonucleoside triphosphate pools in human diploid fibroblasts and their modulation by hydroxyurea and deoxynucleosides. Biochem Pharmacol 33: 1515\u20131518","journal-title":"Biochem Pharmacol"},{"key":"BFEMMM201910419_CR84","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.aao3172","volume":"358","author":"K Somyajit","year":"2017","unstructured":"Somyajit K, Gupta R, Sedlackova H, Neelsen KJ, Ochs F, Rask MB, Choudhary C, Lukas J (2017) Redox\u2010sensitive alteration of replisome architecture safeguards genome integrity. Science 358: 797\u2013802","journal-title":"Science"},{"key":"BFEMMM201910419_CR85","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1073\/pnas.78.8.5132","volume":"78","author":"JA Streifel","year":"1981","unstructured":"Streifel JA, Howell SB (1981) Synergistic interaction between 1\u2010beta\u2010D\u2010arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in\u00a0vitro. Proc Natl Acad Sci USA 78: 5132\u20135136","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201910419_CR86","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.ejca.2015.06.117","volume":"51","author":"DJPM Stumpel","year":"2015","unstructured":"Stumpel DJPM, Schneider P, Pieters R, Stam RW (2015) The potential of clofarabine in MLL\u2010rearranged infant acute lymphoblastic leukaemia. Eur J Cancer 51: 2008\u20132021","journal-title":"Eur J Cancer"},{"key":"BFEMMM201910419_CR87","first-page":"729","volume":"76","author":"M Tanaka","year":"1985","unstructured":"Tanaka M, Kimura K, Yoshida S (1985) Mechanism of synergistic cell killing by hydroxyurea and cytosine arabinoside. Jpn J Cancer Res 76: 729\u2013735","journal-title":"Jpn J Cancer Res"},{"key":"BFEMMM201910419_CR88","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0161-5890(94)90173-2","volume":"31","author":"DA Tanguay","year":"1994","unstructured":"Tanguay DA, Chiles TC (1994) Cell cycle\u2010specific induction of Cdk2 expression in B lymphocytes following antigen receptor cross\u2010linking. Mol Immunol 31: 643\u2013649","journal-title":"Mol Immunol"},{"key":"BFEMMM201910419_CR89","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1517\/14796694.1.1.7","volume":"1","author":"L Toschi","year":"2005","unstructured":"Toschi L, Finocchiaro G, Bartolini S, Gioia V, Cappuzzo F (2005) Role of gemcitabine in cancer therapy. Future Oncol (London, England) 1: 7\u201317","journal-title":"Future Oncol (London, England)"},{"key":"BFEMMM201910419_CR90","doi-asserted-by":"crossref","first-page":"e10070240","DOI":"10.3390\/cancers10070240","volume":"10","author":"N Tsesmetzis","year":"2018","unstructured":"Tsesmetzis N, Paulin CBJ, Rudd SG, Herold N (2018) Nucleobase and nucleoside analogues: resistance and re\u2010sensitisation at the level of pharmacokinetics, pharmacodynamics and metabolism. Cancers 10: e10070240","journal-title":"Cancers"},{"key":"BFEMMM201910419_CR91","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1158\/0008-5472.CAN-16-0584","volume":"76","author":"NC Valerie","year":"2016","unstructured":"Valerie NC, Hagenkort A, Page BD, Masuyer G, Rehling D, Carter M, Bevc L, Herr P, Homan E, Sheppard NG et\u00a0al (2016) NUDT15 hydrolyzes 6\u2010thio\u2010DeoxyGTP to mediate the anticancer efficacy of 6\u2010thioguanine. Can Res 76: 5501\u20135511","journal-title":"Can Res"},{"key":"BFEMMM201910419_CR92","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1158\/1535-7163.MCT-13-0424","volume":"12","author":"AA Van Linden","year":"2013","unstructured":"Van Linden AA, Baturin D, Ford JB, Fosmire SP, Gardner L, Korch C, Reigan P, Porter CC (2013) Inhibition of Wee1 sensitizes cancer cells to antimetabolite chemotherapeutics in\u00a0vitro and in\u00a0vivo, independent of p53 functionality. Mol Cancer Ther 12: 2675\u20132684","journal-title":"Mol Cancer Ther"},{"key":"BFEMMM201910419_CR93","first-page":"3286","volume":"40","author":"CT Walsh","year":"1980","unstructured":"Walsh CT, Craig RW, Agarwal RP (1980) Increased activation of 1\u2010beta\u2010D\u2010arabinofuranosylcytosine by hydroxyurea in L1210 cells. Can Res 40: 3286\u20133292","journal-title":"Can Res"},{"key":"BFEMMM201910419_CR94","doi-asserted-by":"crossref","first-page":"14324","DOI":"10.1073\/pnas.0706803104","volume":"104","author":"J Wang","year":"2007","unstructured":"Wang J, Lohman GJ, Stubbe J (2007) Enhanced subunit interactions with gemcitabine\u20105\u2032\u2010diphosphate inhibit ribonucleotide reductases. Proc Natl Acad Sci USA 104: 14324\u201314329","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201910419_CR95","doi-asserted-by":"crossref","first-page":"21407","DOI":"10.1074\/jbc.C116.751446","volume":"291","author":"Z Wang","year":"2016","unstructured":"Wang Z, Bhattacharya A, Villacorta J, Diaz\u2010Griffero F, Ivanov DN (2016) Allosteric activation of SAMHD1 by deoxynucleotidetriphosphate (dNTP)\u2010dependent tetramerization requires dNTP concentrations that are similar to dNTP concentrations observed in cycling T cells. J Biol Chem 291: 21407\u201321413","journal-title":"J Biol Chem"},{"key":"BFEMMM201910419_CR96","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1021\/acschembio.6b00303","volume":"11","author":"S Wisitpitthaya","year":"2016","unstructured":"Wisitpitthaya S, Zhao Y, Long MJ, Li M, Fletcher EA, Blessing WA, Weiss RS, Aye Y (2016) Cladribine and fludarabine nucleotides induce distinct hexamers defining a common mode of reversible RNR inhibition. ACS Chem Biol 11: 2021\u20132032","journal-title":"ACS Chem Biol"},{"key":"BFEMMM201910419_CR97","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1182\/bloodadvances.2017013870","volume":"2","author":"P Xiao","year":"2018","unstructured":"Xiao P, Sandhow L, Heshmati Y, Kondo M, Bouderlique T, Dolinska M, Johansson AS, Sigvardsson M, Ekblom M, Walfridsson J et\u00a0al (2018) Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice. Blood Adv 2: 1480\u20131494","journal-title":"Blood Adv"},{"key":"BFEMMM201910419_CR98","first-page":"3030","volume":"56","author":"KC Xie","year":"1996","unstructured":"Xie KC, Plunkett W (1996) Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2\u2010chloro\u20109\u2010(2\u2010deoxy\u20102\u2010fluoro\u2010beta\u2010D\u2010arabinofuranosyl) adenine. Can Res 56: 3030\u20133037","journal-title":"Can Res"},{"key":"BFEMMM201910419_CR99","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","volume":"13","author":"B Yadav","year":"2015","unstructured":"Yadav B, Wennerberg K, Aittokallio T, Tang J (2015) Searching for drug synergy in complex dose\u2010response landscapes using an interaction potency model. Comput Struct Biotechnol J 13: 504\u2013513","journal-title":"Comput Struct Biotechnol J"},{"key":"BFEMMM201910419_CR100","doi-asserted-by":"crossref","first-page":"13279","DOI":"10.1074\/jbc.M115.646588","volume":"290","author":"J Yan","year":"2015","unstructured":"Yan J, Hao C, DeLucia M, Swanson S, Florens L, Washburn MP, Ahn J, Skowronski J (2015) CyclinA2\u2010cyclin\u2010dependent kinase regulates SAMHD1\u00a0protein phosphohydrolase domain. J Biol Chem 290: 13279\u201313292","journal-title":"J Biol Chem"},{"key":"BFEMMM201910419_CR101","first-page":"1","volume":"19","author":"JW Yarbro","year":"1992","unstructured":"Yarbro JW (1992) Mechanism of action of hydroxyurea. Semin Oncol 19: 1\u201310","journal-title":"Semin Oncol"},{"key":"BFEMMM201910419_CR102","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.leukres.2005.12.013","volume":"30","author":"KW Yee","year":"2006","unstructured":"Yee KW, Cortes J, Ferrajoli A, Garcia\u2010Manero G, Verstovsek S, Wierda W, Thomas D, Faderl S, King I, O'Brien SM et\u00a0al (2006) Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome. Leuk Res 30: 813\u2013822","journal-title":"Leuk Res"},{"key":"BFEMMM201910419_CR103","first-page":"516","volume":"71","author":"CF Zhu","year":"2015","unstructured":"Zhu CF, Wei W, Peng X, Dong YH, Gong Y, Yu XF (2015) The mechanism of substrate\u2010controlled allosteric regulation of SAMHD1 activated by GTP. Acta Crystallogr D Biol Crystallogr 71: 516\u2013524","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"BFEMMM201910419_CR104","first-page":"139","volume":"12","author":"R Zittoun","year":"1985","unstructured":"Zittoun R, Marie JP, Zittoun J, Marquet J, Haanen C (1985) Modulation of cytosine arabinoside (ara\u2010C) and high\u2010dose ara\u2010C in acute leukemia. Semin Oncol 12: 139\u2013143","journal-title":"Semin Oncol"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201910419.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.201910419","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.201910419\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.201910419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201910419.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:31:32Z","timestamp":1779085892000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.201910419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,6]]}},"alternative-id":["BFEMMM201910419"],"URL":"https:\/\/doi.org\/10.15252\/emmm.201910419","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,17]]},"assertion":[{"value":"1 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.L. is employed at AstraZeneca. C.B.J.P is currently employed by Research Institutes of Sweden.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"EMMM201910419"}}